Considerations in the use of lipid-based drug products.
T
T
Madej
D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000737:chemistry; D004317:Doxorubicin / Q000009:adverse effects* / Q000737:chemistry; D004337:Drug Carriers; D005119:Extravasation of Diagnostic and Therapeutic Materials / Q000209:etiology* / Q000473:pathology; D006801:Humans; D007249:Inflammation; D007262:Infusions, Intravenous; D008081:Liposomes; D009336:Necrosis
D000970:Antineoplastic Agents; D004337:Drug Carriers; D008081:Liposomes; D004317:Doxorubicin